Investigation of Medication Errors in Intensive Care Units

The SIG for the Investigation of Medication Errors in Intensive Care Units (financially supported by BD) seeks to determine the prevalence of medication errors in intensive care units, their causes or contributing factors, and strategies to improve medication safety and prevent medication errors. The findings of this group will be published in form of a report and policy recommendations towards the end of this year.

SIG survey on medication error prevention strategies in intensive care settings across Europe

The SIG for the Investigation of Medication Errors in Intensive Care Units (ICUs) is conducting research on medication error prevention strategies in intensive care settings across Europe. Healthcare professionals working in any intensive care setting involved with medicines and medication safety officers were invited to take part in a survey which ran from March 2022 to 8th of May 2022.

 

Join the focus group interviews of EAHP's SIG or the Investigation of Medication Errors in Intensive Care Units

EAHP's Special Interest Group for the Investigation of Medication Errors in Intensive Care Units (ICU) would like to invite you to take part in an online focus group interview.

The focus group interview is a part of extensive study composed of a literature review, a survey and focus group interviews on medication error prevention strategies and patient safety culture within the ICU environment across Europe. The language used in the focus group interview will be English.

The aim of the focus group is to explore the experiences of healthcare professionals of patient safety culture and medication error prevention strategies in intensive care settings across Europe. We hope that the information we get, along with other research we are conducting, can be used to develop policy recommendations for medication safety improvement in ICUs across Europe. This research has received ethical approval from the Ethical Review Board in the Humanities and Social and Behavioural Sciences, University of Helsinki (18/2022, 18.3.2022).

Healthcare professionals working in any intensive care setting involved with medicines or in any medication safety role can take part in this study.

Participation in this research is completely voluntary, and all the information you provide will be kept confidential. All data collected will be pseudonymised, meaning that any data identifying participants will be removed before the analyses. Please read the attached information sheet on the study which provides further detail on the research.

If you are interested in taking part in this research, please email the Principal Investigator, Adjunct Professor Raisa Laaksonen (raisa.laaksonen[at]helsinki[dot]fi), University of Helsinki, Finland, co-chair of the EAHP Special Interest Group by the 10th of May 2022.

The focus group interview will be arranged using an online videoconferencing facility on

  • Friday, 13th of May (12.00 to 14.00 CET)
  • Tuesday, 17th of May (13.00 to 15.00 CET)
  • Wednesday, 18th of May (12.00 to 14.00 CET)
  • Monday, 23rd of May (12.00 to 14.00 CET)

Thank you for considering to take part in this research!

Access the Participant Information Sheet HERE

Access the Consent Form HERE 

 

Last update: 24 May 2022